Healome Therapeutics Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $2.66M

  • Investors
  • 11

Healome Therapeutics General Information

Description

Developer of treatments for eye conditions of ocular diseases designed for eye trauma therapeutics. The company offers novel fluid-gel material that flows like a liquid and self-structures into a thin, clear, protective layer over the surface of the eye, which is gradually dispersed, enabling patients to get effective and longer lasting relief.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Birmingham Research Park
  • 97 Vincent Drive
  • Birmingham B15 2SQ
  • England, United Kingdom
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Corporate Office
  • Birmingham Research Park
  • 97 Vincent Drive
  • Birmingham B15 2SQ
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Healome Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Seed Round 07-Jul-2026 $2.66M Completed Clinical Trials - Phase 1
4. Seed Round 21-Oct-2021 Completed Clinical Trials - Phase 1
3. Grant Completed Clinical Trials - Phase 1
2. Accelerator/Incubator Completed Clinical Trials - Phase 1
1. University Spin-Out 11-Jan-2021 Completed Clinical Trials - Phase 1
To view Healome Therapeutics’s complete valuation and funding history, request access »

Healome Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary A
Ordinary
Ordinary A 1,263,158 $0.000133 $0.16 $0.16 1x $0.16 8.24%
To view Healome Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Healome Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Healome Therapeutics Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cure EB Other Minority
DEBRA Research Corporation Minority
Empirical Ventures Venture Capital Minority
Midlands Mindforge Impact Investing
Oshen Holdings Family Office Minority
You’re viewing 5 of 11 investors. Get the full list »

Healome Therapeutics FAQs

  • When was Healome Therapeutics founded?

    Healome Therapeutics was founded in 2021.

  • Where is Healome Therapeutics headquartered?

    Healome Therapeutics is headquartered in Birmingham, United Kingdom.

  • What is the size of Healome Therapeutics?

    Healome Therapeutics has 5 total employees.

  • What industry is Healome Therapeutics in?

    Healome Therapeutics’s primary industry is Drug Discovery.

  • Is Healome Therapeutics a private or public company?

    Healome Therapeutics is a Private company.

  • What is the current valuation of Healome Therapeutics?

    The current valuation of Healome Therapeutics is .

  • What is Healome Therapeutics’s current revenue?

    The current revenue for Healome Therapeutics is .

  • How much funding has Healome Therapeutics raised over time?

    Healome Therapeutics has raised $3.21M.

  • Who are Healome Therapeutics’s investors?

    Cure EB, DEBRA Research, Empirical Ventures, Midlands Mindforge, and Oshen Holdings are 5 of 11 investors who have invested in Healome Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process